Malignant pleural mesothelioma (MPM) is a deadly disease that occurs in 2,000 to 3,000
people each year in the United States. Although MPM is an extremely difficult disease to …

Malignant mesothelioma is a fatal asbestos-associated malignancy originating from the
lining cells (mesothelium) of the pleural and peritoneal cavities, as well as the pericardium …

Purpose To provide evidence-based recommendations to practicing physicians and others
on the management of malignant pleural mesothelioma. Methods ASCO convened an …

Refer all patients with a chest X-ray suggestive of MPM urgently (via the 2-week wait
suspected cancer pathway in England and Wales). Consider referral for further investigation …

BACKGROUND: Currently, no tumor‐node‐metastasis (TNM) staging system exists for
patients with diffuse malignant peritoneal mesothelioma (DMPM). The primary objective was …

Introduction: The primary objective of the present systematic review was to evaluate the
safety and efficacy of extrapleural pneumonectomy (EPP) for patients with malignant pleural …

Objective We have previously described patterns of failure after extrapleural
pneumonectomy and multimodality therapy for malignant pleural mesothelioma and sought …

Malignant pleural mesothelioma (MPM) is a relevant public health issue. A large amount of
data indicate a relationship between mesothelioma and asbestos exposure. MPM incidence …

OBJECTIVES There is a body of opinion that advocates extrapleural pneumonectomy (EPP)
as the only radical treatment option for locally advanced (T3/T4) malignant pleural …

Purpose We previously reported our technique for delivering intensity modulated radiation
therapy (IMRT) to the entire pleura while attempting to spare the lung in patients with …